Tula, Tula, Russian Federation
Tula, Tula, Russian Federation
Magniy otnositsya k makroelementam, neobhodimym dlya normal'noy zhiznedeyatel'nosti organizma. Korrekciya deficita magniya provoditsya preparatami magniya. Issledovaniya pokazyvayut celesoobraznost' primeneniya orotata magniya pri mnogih serdechno-sosudistyh zabolevaniyah, chto obuslovleno anitiishemicheskim, antiaritmicheskim, gipotenzivnym i drugimi effektami.
magniy, gipomagniemiya, effekty preparata Magnerot, serdechno-sosudistye zabolevaniya
1. Dreosti E. Magnesium status and health // Nutr. Rev. 1995. Vol. 53. P. 23-27.
2. Gorodeckiy V.V., Talibov O.B. Preparaty magniya v medicinskoy praktike. Malayaenciklopediyamagniya. M.: Medpraktika, 2008. 43 s.
3. Petroianu A., Barquete J., Plentz E. G. Acute effects of alcohol ingestion on the human serum concentrations of calcium and magnesium // J. Int. Med. Res. 1991. Sep.-Oct. Vol. 19 (5). P. 410-413.
4. Spasov A.A. Magniy v medicinskoy praktike // Volgograd, 2000; 268.
5. Rebrov V.G., Gromova O.A. Vitaminy i mikroelementy. M.: Alev-V, 2003.
6. Korovina N.A., Tvorogova T.M., Gavryushova L.P. Primenenie preparatov magniya pri serdechno-sosudistyh zabolevaniyah u detey // Lechaschiy vrach. 2006; 3.
7. Akatova E.V., Nikolin O.P., Martynov A.I. Effektivnost' primeneniya preparata «Magnerot» pri proyavleniyah sindroma sosudistyh narusheniy i gemorragicheskogo sindroma u bol'nyh s idiopaticheskim prolapsom mitral'nogo klapana // Kardiosomatika. 2011;1:13-17.
8. Akatova E.V., Nikolin O.P., Martynov A.I. Klinicheskaya effektivnost' orotata magniya u pacientov s narusheniyami ritma i arterial'noy gipertoniey pri prolapse mitral'nogo klapana // Kardiovaskulyarnaya terapiya i profilaktika. 2009;8(8):9-12.
9. Akatova E.V., Suhanova E.D., Mel'nik O.O., Martynov A.I. Dinamika pokazateley funkcional'nogo sostoyaniya serdechno-sosudistoy sistemy u bol'nyh s idiopaticheskim prolapsom mitral'nogo klapana na fone terapii Magnerotom i alprazolamom // Klinicheskaya medicina. 2008;86(3):55-58.
10. Nechaeva G.I., Moskvina Yu.V., Druk I.V., Loginova E.N. Vremennye pokazateli variabel'nosti serdechnogo ritma u pacientov s aritmicheskim sindromom, associirovannym s displaziey soedinitel'noy tkani na fone priema preparata Magnerot //Sibirskiy medicinskiy zhurnal. 2011;26(3-2):59-63.
11. Provotorov V.M., Kotochigova T.V. Dinamika pokazateley funkcii vneshnego dyhaniya u bol'nyh hronicheskoy obstruktivnoy bolezn'yu legkih i hronicheskoy serdechnoy nedostatochnost'yu s primeneniem preparata Magnerot // Vrach-aspirant. 2014;62(1,2):344-348.
12. Schegol'kov A.M., Klyachkin L.M., Marochkina E.B., Voroncova G.N. Primenenie magniya i orotovoy kisloty v reabilitacii bol'nyh s sochetannoy kardiorespiratornoy patologiey// Mikroelementy v medicine. 2003;4(2):16-18.
13. Stepura OB, Martynow AI. Magnesium orotate in severe congestive heart failure // IntJCardiol. 2009;134(1):145-147.
14. Belovol A.N., Krapivko S.A., Kravchun P.P. Gipomagniemiya kak prediktor dekompensacii hronicheskoy serdechnoy nedostatochnosti u bol'nyh s saharnym diabetom 2-go tipa // Arterial'naya gipertenziya. 2013;4(30):35-39.
15. Kucherenko A.G., Zhirkova O.O., Smirnov I.E., Kupriyanova O.O., Ivanov A.P., Basargina E.N., Markov H.M. Oksid azota u detey s prolapsom mitral'nogo klapana // Pediatriya. Zhurnal im. G.N. Speranskogo. 2005;84(2):13-15.
16. Nechaeva G.I., Moskvina Yu.V., Bunova S.S. Chuvstvitel'nost' adrenoreceptorov u pacientov s narusheniyami serdechnogo ritma na fone displazii soedinitel'noy tkani pri kursovom prieme preparata magniya // Rossiyskiy kardiologicheskiy zhurnal. 2012;4:69-73.
17. Moskvina Yu.V., Nechaeva G.I. Adrenoreaktivnost' u pacientov s aritmicheskim sindromom, associirovannym s displaziey soedinitel'noy tkani na fone priema magniya orotata // Kardiologiya. 2011;51(3):54-57.
18. Shilov A.M., Osiya A.O. Preparaty magniya (Magnerot) i serdechno-sosudistye zabolevaniya v praktike vracha pervichnogo zvena zdravoohraneniya // Trudnyy pacient. 2013. № 12. S.12-19.
19. Korovina N.A., Tvorogova T.M., Gavryusheva L.P. Primenenie preparatov magniya pri serdechno-sosudistyh zabolevaniyah u detey // Lechaschiy vrach. 2006. № 3. S.10-13.
20. Torshin I.Yu., Gromova O.A., Fedotova L.E. i dr. Hemoinformacionnyy analiz molekuly orotovoy kisloty ukazyvaet na protivovospalitel'nye, neyroprotektivnye i kardioprotektivnye svoystva liganda magniya // Farmateka. 2013. № 13. S. 95-103.
21. Jellinek H., Takacs E. Morphological aspects of the effects of orotic acid and magnesium // Arzneimittelforschung. 1995. Vol. 45 (8).P. 836-842.
22. Nedogoda S.V. Rol' preparatov magniya v vedenii pacientov terapevticheskogo profilya // Lechaschiy vrach. 2009. №.6. C. 16-19.
23. Morozova T.E., Durnecova O.S. Preparaty magniya v kardiologicheskoy praktike // Lechaschiy vrach. 2014. № 4. S. 95-99.
24. Zabelina V.D. Magniy i magniysoderzhaschie preparaty. S magniem po zhizni // Consilium-provisorum 2003;3(5): 27-30.
25. Todd J. LeDuc, John D. Carr. Magnesium Sulfate For Conversion of Supraventricular Tachycardia Refractory to Intravenous Adenosine // Annals of Emergency Medicine. 1996; 27: 3: 375-378.
26. Liao F., Folsom A.R., Brancati F.L. Is low magnesium concentration a risk factor for coronary heart disease? The Atherosclerosis Risk in Communities (ARIC) Study // Am. Heart J. 1998. Vol. 136 (3). P. 480-490.
27. Shechter M. Does magnesium have a role in the treatment of patients with coronary artery disease? // Am. J. Cardiovasc. Drugs. 2003. Vol. 3 (4). P. 231-239.
28. Lazebnik L.B., Drozdova S.L. Korrekciya magnievogo deficita pri serdechno-sosudistoy patologii // Kardiologiya. 1997. № 5. S. 103-104.
29. Diaz R., Paolasso E.C., Piegas L.S. et al. on behalf of the ECLA (EstudiosCardiologicosLatinoamerica) collaborative group. Metabolic modulation of acute myocardial infarction. The ECLA glucose-insulin-potassium pilot trial // Circulation. 1998. Vol. 98. P. 2227-2234.
30. Fath-Ordoubadi F., Beatt K.J. Glucose-insulin-potassium therapy for treatment of acute myocardial infarction. An overview of randomized placebo - controlled trials // Circulation. 1997. Vol. 96. P. 1152-1156.
